SLAMF7 and cancer: This differs from findings in cancer immunotherapy, where SLAMF7 has emerged as an attractive therapeutic target owing to its ability to specifically activate NK cells within tumors and promote immunogenic cell death.49 The function of SLAMF7 in both inflammation and cancer immunotherapy depends on its specific environment and molecular mechanisms.